StonvexLoading…
StonvexStonvexStonvexCore line items from TSHA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $9.77M | $4.29M | $4.29M |
Operating Income | $-43.49M | $-110.50M | $-82.20M | $-48.17M |
Net Income | $-42.41M | $-109.00M | $-81.14M | $-48.41M |
EPS (Diluted) | $-0.12 | $-0.34 | $-0.26 | $-0.17 |
Total Assets | $300.35M | $343.32M | $316.55M | $333.33M |
Total Liabilities | $88.41M | $96.38M | $97.56M | $84.60M |
Cash & Equivalents | $276.58M | $319.77M | $297.34M | $312.76M |
Free Cash Flow OCF − CapEx | $-40.90M | $-93.83M | $-66.86M | $-42.58M |
Shares Outstanding | 287.28M | 285.05M | 273.92M | 272.73M |